Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
HON
|
Linnet F Deily
Director |
SELL
Open market or private sale
|
Direct | 3,066 Reduced 26.01% |
$484,796
$158.12 p/Share
|
Jul 30
2018 |
LQDA
|
Glaxosmithkline PLC |
BUY
Open market or private purchase
|
Indirect | 148,818 Added 19.25% |
$1,636,998
$11.0 p/Share
|
Jul 30
2018 |
ASB
|
Christopher Del Moral Niles
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 3,500 Reduced 12.95% |
$97,125
$27.75 p/Share
|
Jul 30
2018 |
TUSK
|
Meh Sub LLC |
SELL
Open market or private sale
|
Direct | 266,026 Reduced 1.2% |
$10,111,648
$38.01 p/Share
|
Jul 30
2018 |
KMPH
|
Delaware Street Capital Master Fund, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 304,283 Added 12.68% |
$1,217,132
$4.0 p/Share
|
Jul 30
2018 |
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 2,200 Added 0.01% |
$9,372
$4.26 p/Share
|
Jul 30
2018 |
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 0 Added 0.0% |
-
|
Jul 30
2018 |
EYE
|
Berkshire Partners Holdings LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 2,633,406 Reduced 35.38% |
$100,754,109
$38.26 p/Share
|
Jul 30
2018 |
EYE
|
Berkshire Partners Holdings LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 48,151 Reduced 65.41% |
$1,842,257
$38.26 p/Share
|
Jul 30
2018 |
SBBP
|
Cdk Associates, L.L.C.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 70,000 Added 1.17% |
$326,200
$4.66 p/Share
|
Jul 30
2018 |
FHI
|
Michael J Farrell |
BUY
Open market or private purchase
|
Indirect | 65,000 Added 39.26% |
$1,574,950
$24.23 p/Share
|
Jul 30
2018 |
STKS
|
David Kanen
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 2,100 Added 0.07% |
$5,880
$2.8 p/Share
|
Jul 30
2018 |
WOW
|
Crestview Partners Iii Gp, L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 43,000 Added 0.15% |
$454,940
$10.58 p/Share
|
Jul 30
2018 |
BBQ
|
David Kanen
Director |
BUY
Open market or private purchase
|
Indirect | 3,693 Added 0.37% |
$23,783
$6.44 p/Share
|
Jul 30
2018 |
SBBP
|
Cdk Associates, L.L.C.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 209,300 Added 3.45% |
$992,082
$4.74 p/Share
|
Jul 27
2018 |
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 17,145 Added 0.1% |
$75,952
$4.43 p/Share
|
Jul 27
2018 |
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 0 Added 0.0% |
-
|
Jul 27
2018 |
STKS
|
David Kanen
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 4,831 Added 0.16% |
$13,189
$2.73 p/Share
|
Jul 27
2018 |
WOW
|
Crestview Partners Iii Gp, L.P.
Director |
BUY
Open market or private purchase
|
Indirect | 57,000 Added 0.2% |
$599,070
$10.51 p/Share
|
Jul 27
2018 |
PTC
|
Andrew Miller
EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 23,487 Reduced 22.43% |
$2,276,360
$96.92 p/Share
|
Jul 27
2018 |
FNLC
|
Steven Parady
EVP, Chief Fiduciary Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 2.01% |
$30,450
$30.45 p/Share
|
Jul 27
2018 |
SNV
|
Diana M Murphy
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 23.96% |
$99,360
$49.68 p/Share
|
Jul 27
2018 |
KWR
|
Jan Nieman
VP/GL - Grease, FP, GS, Mktg. |
SELL
Open market or private sale
|
Direct | 510 Reduced 8.81% |
$84,150
$165.0 p/Share
|
Jul 27
2018 |
PLNT
|
Christopher Rondeau |
SELL
Open market or private sale
|
Indirect | 15,235 Reduced 100.0% |
$749,867
$49.22 p/Share
|
Jul 27
2018 |
TZOO
|
Azzurro Capital Inc
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 60,000 Reduced 0.91% |
$809,400
$13.49 p/Share
|
Jul 27
2018 |
EGN
|
Icahn Carl C |
BUY
Open market or private purchase
|
Indirect | 29,200 Added 0.51% |
$2,163,428
$74.09 p/Share
|
Jul 27
2018 |
ATEX
|
Owl Creek Asset Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 33,000 Added 1.24% |
$922,020
$27.94 p/Share
|
Jul 27
2018 |
FEIM
|
Edenbrook Capital, LLC
Director |
BUY
Open market or private purchase
|
Indirect | 50 Added 0.0% |
$396
$7.93 p/Share
|
Jul 27
2018 |
NKE
|
Elliott Hill
PRES:CONSUMER & MKTPLC |
SELL
Open market or private sale
|
Direct | 5,741 Reduced 5.37% |
$448,774
$78.17 p/Share
|
Jul 27
2018 |
HON
|
Vimal Kapur
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 9,996 Reduced 46.69% |
$1,591,863
$159.25 p/Share
|
Jul 27
2018 |
LMT
|
Marillyn A Hewson
Executive Chairman |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 26.34% |
$8,095,500
$323.82 p/Share
|
Jul 27
2018 |
GL
|
John Henry Rogers Jr |
SELL
Open market or private sale
|
Direct | 875 Reduced 100.0% |
$76,624
$87.57 p/Share
|
Jul 27
2018 |
FNF
|
Brent B Bickett
Executive Vice President |
SELL
Open market or private sale
|
Direct | 50,000 Reduced 9.01% |
$2,034,000
$40.68 p/Share
|
Jul 27
2018 |
SNV
|
Allan E Kamensky
EVP and General Counsel |
BUY
Open market or private purchase
|
Direct | 1,000 Added 1.49% |
$50,060
$50.06 p/Share
|
Jul 27
2018 |
DAL
|
Craig M Meynard
VP and Chief Acctg Officer |
SELL
Open market or private sale
|
Direct | 1,793 Reduced 20.0% |
$97,378
$54.31 p/Share
|
Jul 27
2018 |
TRU
|
James M Peck
Director |
SELL
Open market or private sale
|
Direct | 131,750 Reduced 33.84% |
$9,453,062
$71.75 p/Share
|
Jul 27
2018 |
ALRN
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 6,458 Reduced 0.26% |
$21,828
$3.38 p/Share
|
Jul 27
2018 |
QCOM
|
Alexander H Rogers
President QTL & Global Affairs |
SELL
Open market or private sale
|
Direct | 828 Reduced 10.35% |
$52,495
$63.4 p/Share
|
Jul 27
2018 |
RF
|
Susan W Matlock
Director |
SELL
Open market or private sale
|
Direct | 24,000 Reduced 61.68% |
$444,000
$18.5 p/Share
|
Jul 27
2018 |
LAB
|
Levin Capital Strategies, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 20,029 Added 0.09% |
$123,779
$6.18 p/Share
|
Jul 27
2018 |
AGFS
|
Dow Du Pont Inc.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 599 Added 0.0% |
$4,193
$7.0 p/Share
|
Jul 27
2018 |
EPE
|
Apollo Management Holdings Gp, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 241,140 Reduced 0.22% |
$518,451
$2.15 p/Share
|
Jul 27
2018 |
MIC
|
Macquarie Group LTD
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 14,812 Added 0.14% |
$666,096
$44.97 p/Share
|
Jul 26
2018 |
AGRX
|
Perceptive Advisors LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 298,628 Reduced 8.46% |
$89,588
$0.3 p/Share
|
Jul 26
2018 |
SBBP
|
Cdk Associates, L.L.C.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 39,800 Added 0.7% |
$196,612
$4.94 p/Share
|
Jul 26
2018 |
ALRN
|
Novartis Bioventures LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 7,937 Reduced 0.32% |
$28,811
$3.63 p/Share
|
Jul 26
2018 |
INTC
|
Navin Shenoy
EVP, GM - Data Platforms Group |
SELL
Open market or private sale
|
Direct | 1,265 Reduced 3.09% |
$66,324
$52.43 p/Share
|
Jul 26
2018 |
INTC
|
Steven Ralph Rodgers
EVP General Counsel |
SELL
Open market or private sale
|
Direct | 2,213 Reduced 10.51% |
$116,028
$52.43 p/Share
|
Jul 26
2018 |
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 4,081 Added 0.02% |
$18,283
$4.48 p/Share
|
Jul 26
2018 |
AVTX
|
Armistice Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 0 Added 0.0% |
-
|
Jul 26
2018 |